Mixed typical and atypical hemolytic uremic syndrome in a kidney transplant patient

J Nephrol. 2022 Jan;35(1):343-346. doi: 10.1007/s40620-021-01112-z. Epub 2021 Jul 5.

Authors

Mattia Rossi¹, Giuseppina Pessolano², Chiara Caletti², Vincenzo De Biase², Giovanni Gambaro²

Affiliations

¹ Division of Nephrology, Department of Medicine, University of Verona, Piazzale Aristide Stefani, 1, 37126, Verona, Italy. mattia.rossi@aovr.veneto.it.
² Division of Nephrology, Department of Medicine, University of Verona, Piazzale Aristide Stefani, 1, 37126, Verona, Italy.

PMID: 34224089
DOI: 10.1007/s40620-021-01112-z

No abstract available

Keywords: Thrombotic microangiopathy and kidney transplantation; Typical and atypical hemolytic uremic syndrome.

MeSH terms

Atypical Hemolytic Uremic Syndrome* / diagnosis
Atypical Hemolytic Uremic Syndrome* / etiology
Complement Inactivating Agents
Humans
Kidney Transplantation* / adverse effects
Thrombotic Microangiopathies*

Substances

Complement Inactivating Agents